Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: Analysis of 519 patients.
Eur J Surg Oncol
; 40(5): 515-520, 2014 May.
Article
in En
| MEDLINE
| ID: mdl-24462284
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Appendiceal Neoplasms
/
Peritoneal Neoplasms
/
Pseudomyxoma Peritonei
/
Carcinoembryonic Antigen
/
Biomarkers, Tumor
/
CA-19-9 Antigen
/
CA-125 Antigen
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Eur J Surg Oncol
Year:
2014
Type:
Article